These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 8604204

  • 1. Amyloid, aluminum and the aetiology of Alzheimer's disease.
    Exley C.
    Med J Aust; 1996 Feb 19; 164(4):252-3. PubMed ID: 8604204
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Aluminum promotes the aggregation of Alzheimer's amyloid beta-protein in vitro.
    Kawahara M, Muramoto K, Kobayashi K, Mori H, Kuroda Y.
    Biochem Biophys Res Commun; 1994 Jan 28; 198(2):531-5. PubMed ID: 7507666
    [Abstract] [Full Text] [Related]

  • 4. [Genetic factors and aluminum are possible causes of Alzheimer's disease].
    Lake S, Winblad B.
    Lakartidningen; 1991 Apr 03; 88(14):1279-81. PubMed ID: 2016974
    [No Abstract] [Full Text] [Related]

  • 5. Aluminum modulates effects of beta amyloid(1-42) on neuronal calcium homeostasis and mitochondria functioning and is altered in a triple transgenic mouse model of Alzheimer's disease.
    Drago D, Cavaliere A, Mascetra N, Ciavardelli D, di Ilio C, Zatta P, Sensi SL.
    Rejuvenation Res; 2008 Oct 03; 11(5):861-71. PubMed ID: 18788899
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Presenilins and Alzheimer's disease: the role of A beta 42.
    Eckman CB.
    J Neural Transm Suppl; 1998 Oct 03; 53():181-4. PubMed ID: 9700656
    [Abstract] [Full Text] [Related]

  • 8. Physiochemical characterization of the Alzheimer's disease-related peptides A beta 1-42Arctic and A beta 1-42wt.
    Johansson AS, Berglind-Dehlin F, Karlsson G, Edwards K, Gellerfors P, Lannfelt L.
    FEBS J; 2006 Jun 03; 273(12):2618-30. PubMed ID: 16817891
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Advances in understanding the pathogenetic mechanisms of Alzheimer's disease.
    Govoni S, Lanni C, Racchi M.
    Funct Neurol; 2001 Jun 03; 16(4 Suppl):17-30. PubMed ID: 11996513
    [No Abstract] [Full Text] [Related]

  • 12. [Significance of intracellular A beta in Alzheimer's disease].
    Tabira T.
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2002 Oct 03; 22(5):175-80. PubMed ID: 12451689
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Mean age of onset in familial Alzheimer's disease is determined by amyloid beta 42.
    Duering M, Grimm MO, Grimm HS, Schröder J, Hartmann T.
    Neurobiol Aging; 2005 Jun 03; 26(6):785-8. PubMed ID: 15718035
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Heritability of plasma amyloid beta in typical late-onset Alzheimer's disease pedigrees.
    Ertekin-Taner N, Graff-Radford N, Younkin LH, Eckman C, Adamson J, Schaid DJ, Blangero J, Hutton M, Younkin SG.
    Genet Epidemiol; 2001 Jul 03; 21(1):19-30. PubMed ID: 11443731
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Restored degradation of the Alzheimer's amyloid-beta peptide by targeting amyloid formation.
    Crouch PJ, Tew DJ, Du T, Nguyen DN, Caragounis A, Filiz G, Blake RE, Trounce IA, Soon CP, Laughton K, Perez KA, Li QX, Cherny RA, Masters CL, Barnham KJ, White AR.
    J Neurochem; 2009 Mar 03; 108(5):1198-207. PubMed ID: 19141082
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.